|
Volumn 21, Issue 3, 2003, Pages 189-192
|
Anergy testing in patients with head and neck cancer
a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
FUNGUS ANTIGEN;
HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY;
MEASLES MUMPS RUBELLA VACCINE;
PREDNISOLONE;
TETANUS TOXOID;
TUBERCULIN;
ADOLESCENT;
ADULT;
AGE;
AGED;
ARTICLE;
CANDIDA ALBICANS;
CELLULAR IMMUNITY;
CLINICAL ARTICLE;
CLONAL ANERGY;
CONTROLLED STUDY;
DIAGNOSTIC PROCEDURE;
DOSE RESPONSE;
DRUG USE;
ECZEMA;
ERYTHEMA;
FEMALE;
GENDER;
HEAD AND NECK CANCER;
HUMAN;
IMMUNE DEFICIENCY;
IMMUNE FUNCTION TEST;
IMMUNE STATUS;
MALE;
PATIENT SELECTION;
SCHOOL CHILD;
SCREENING TEST;
SKIN DISEASE;
SKIN INDURATION;
SKIN MANIFESTATION;
STATISTICAL SIGNIFICANCE;
TIME;
ADULT;
AGED;
CHILD;
CLONAL ANERGY;
FEMALE;
FOLLOW-UP STUDIES;
HEAD AND NECK NEOPLASMS;
HUMANS;
MALE;
MIDDLE AGED;
NEOPLASM STAGING;
SKIN TESTS;
THAILAND;
|
EID: 1542345777
PISSN: 0125877X
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (5)
|
References (7)
|